|
Diabetic Macular Edema Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 103 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, H1, 2012" provides data on the Diabetic Macular Edema clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Diabetic Macular Edema Global Clinical Trials Review, H1, 2012" provides data on the Diabetic Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Macular Edema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Macular Edema. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Diabetic Macular Edema 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Diabetic Macular Edema 25 Subjects Recruited Over a Period of Time 27 Prominent Sponsors 28 Top Companies Participating in Diabetic Macular Edema Therapeutics Clinical Trials 30 Prominent Drug Comparison 32 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 Novartis AG 33 Clinical Trial Overview of Novartis AG 33 Allergan, Inc. 34 Clinical Trial Overview of Allergan, Inc. 34 Pfizer Inc. 35 Clinical Trial Overview of Pfizer Inc. 35 Alimera Sciences, Inc. 36 Clinical Trial Overview of Alimera Sciences, Inc. 36 Regeneron Pharmaceuticals, Inc. 37 Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 37 Bausch & Lomb Incorporated 38 Clinical Trial Overview of Bausch & Lomb Incorporated 38 Vitreoretinal Technologies Inc. 39 Clinical Trial Overview of Vitreoretinal Technologies Inc. 39 Santen Incorporated 40 Clinical Trial Overview of Santen Incorporated 40 SANWA KAGAKU KENKYUSHO CO.,LTD. 41 Clinical Trial Overview of SANWA KAGAKU KENKYUSHO CO.,LTD. 41 iCo Therapeutics Inc. 42 Clinical Trial Overview of iCo Therapeutics Inc. 42 Fovea Pharmaceuticals SA 43 Clinical Trial Overview of Fovea Pharmaceuticals SA 43 CoMentis, Inc. 44 Clinical Trial Overview of CoMentis, Inc. 44 ThromboGenics NV 45 Clinical Trial Overview of ThromboGenics NV 45 OPKO Health, Inc. 46 Clinical Trial Overview of OPKO Health, Inc. 46 Bayer AG 47 Clinical Trial Overview of Bayer AG 47 Eyetech Pharmaceuticals, Inc. 48 Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 48 Eli Lilly and Company 49 Clinical Trial Overview of Eli Lilly and Company 49 Novagali Pharma SA 50 Clinical Trial Overview of Novagali Pharma SA 50 Santen Pharmaceutical Co., Ltd. 51 Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 51 Quark Pharmaceuticals, Inc. 52 Clinical Trial Overview of Quark Pharmaceuticals, Inc. 52 Clinical Trial Overview of Top Universities / Institutes / Hospitals 53 Johns Hopkins University 53 Clinical Trial Overview of Johns Hopkins University 53 Asociacion para Evitar la Ceguera en Mexico I.A.P. 54 Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 54 University of Sao Paulo 55 Clinical Trial Overview of University of Sao Paulo 55 The University of Sydney 56 Clinical Trial Overview of The University of Sydney 56 Medical University of Vienna 57 Clinical Trial Overview of Medical University of Vienna 57 Shaheed Beheshti Medical University 58 Clinical Trial Overview of Shaheed Beheshti Medical University 58 Diabetic Retinopathy Clinical Research Network 59 Clinical Trial Overview of Diabetic Retinopathy Clinical Research Network 59 Federal University of Sao Paulo 60 Clinical Trial Overview of Federal University of Sao Paulo 60 Chinese University of Hong Kong 61 Clinical Trial Overview of Chinese University of Hong Kong 61 Samsung Medical Center 62 Clinical Trial Overview of Samsung Medical Center 62 Glostrup University Hospital 63 Clinical Trial Overview of Glostrup University Hospital 63 University of Heidelberg 64 Clinical Trial Overview of University of Heidelberg 64 Hong Kong Eye Hospital 65 Clinical Trial Overview of Hong Kong Eye Hospital 65 HOSPITAL JUAREZ DE MEXICO 66 Clinical Trial Overview of HOSPITAL JUAREZ DE MEXICO 66 University of Schleswig-Holstein 67 Clinical Trial Overview of University of Schleswig-Holstein 67 Seoul National University Hospital 68 Clinical Trial Overview of Seoul National University Hospital 68 Moorfields Eye Hospital NHS Foundation Trust 69 Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 69 University of Regensburg 70 Clinical Trial Overview of University of Regensburg 70 Medical College of Wisconsin 71 Clinical Trial Overview of Medical College of Wisconsin 71 The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 72 Clinical Trial Overview of The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 72 Five Key Clinical Profiles 73 Appendix 100 Abbreviations 100 Definitions 100 Research Methodology 101 Secondary Research 101 About GlobalData 102 Contact Us 102 Disclaimer 102 Source 103 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Diabetic Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 Diabetic Macular Edema Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Diabetic Macular Edema Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Diabetic Macular Edema Therapeutics Clinical Trials, G7 Countries, 2012* 18 Diabetic Macular Edema Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Diabetic Macular Edema Therapeutics Clinical Trials, E7 Countries, 2012* 20 Diabetic Macular Edema Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Diabetic Macular Edema Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25 Diabetic Macular Edema Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 33 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 34 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 35 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Alimera Sciences, Inc., 2012* 36 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2012* 37 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2012* 38 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Vitreoretinal Technologies Inc., 2012* 39 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Incorporated, 2012* 40 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by SANWA KAGAKU KENKYUSHO CO.,LTD., 2012* 41 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by iCo Therapeutics Inc., 2012* 42 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2012* 43 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by CoMentis, Inc., 2012* 44 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2012* 45 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by OPKO Health, Inc., 2012* 46 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 47 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eyetech Pharmaceuticals, Inc., 2012* 48 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 49 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Novagali Pharma SA, 2012* 50 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2012* 51 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Quark Pharmaceuticals, Inc., 2012* 52 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 53 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2012* 54 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 55 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2012* 56 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 57 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaheed Beheshti Medical University, 2012* 58 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Diabetic Retinopathy Clinical Research Network, 2012* 59 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 60 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 61 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 62 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2012* 63 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 64 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Eye Hospital, 2012* 65 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by HOSPITAL JUAREZ DE MEXICO, 2012* 66 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2012* 67 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 68 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2012* 69 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Regensburg, 2012* 70 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2012* 71 Diabetic Macular Edema Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery, 2012* 72 List of Figures Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Diabetic Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 Diabetic Macular Edema Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Diabetic Macular Edema Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Diabetic Macular Edema Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Diabetic Macular Edema Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Diabetic Macular Edema Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Diabetic Macular Edema Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Diabetic Macular Edema Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 GlobalData Methodology 101 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
